DK1238086T3 - Vaccine til forögelse af immunreaktioner på herpes simplex virus - Google Patents

Vaccine til forögelse af immunreaktioner på herpes simplex virus

Info

Publication number
DK1238086T3
DK1238086T3 DK00983967T DK00983967T DK1238086T3 DK 1238086 T3 DK1238086 T3 DK 1238086T3 DK 00983967 T DK00983967 T DK 00983967T DK 00983967 T DK00983967 T DK 00983967T DK 1238086 T3 DK1238086 T3 DK 1238086T3
Authority
DK
Denmark
Prior art keywords
type
hsv
nucleic acid
protein
mammal
Prior art date
Application number
DK00983967T
Other languages
Danish (da)
English (en)
Inventor
Eric M Mishkin
Robert J Natuk
Michael W Pride
Maninder K Sidhu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1238086T3 publication Critical patent/DK1238086T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00983967T 1999-12-17 2000-12-07 Vaccine til forögelse af immunreaktioner på herpes simplex virus DK1238086T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17231399P 1999-12-17 1999-12-17

Publications (1)

Publication Number Publication Date
DK1238086T3 true DK1238086T3 (da) 2006-06-26

Family

ID=22627181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00983967T DK1238086T3 (da) 1999-12-17 2000-12-07 Vaccine til forögelse af immunreaktioner på herpes simplex virus

Country Status (16)

Country Link
EP (1) EP1238086B1 (ko)
JP (1) JP2003517042A (ko)
KR (1) KR100773390B1 (ko)
CN (1) CN1222619C (ko)
AT (1) ATE319833T1 (ko)
AU (1) AU783730B2 (ko)
BR (1) BR0016419A (ko)
CA (1) CA2406678A1 (ko)
CY (1) CY1105604T1 (ko)
DE (1) DE60026588T2 (ko)
DK (1) DK1238086T3 (ko)
ES (1) ES2258987T3 (ko)
IL (1) IL149810A0 (ko)
MX (1) MXPA02005867A (ko)
PT (1) PT1238086E (ko)
WO (1) WO2001044477A1 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100443116C (zh) * 2002-11-07 2008-12-17 新纳几美国公司 治疗或预防肺炎球菌感染的组合物及其用途
ES2732815T3 (es) 2009-05-22 2019-11-26 Genocea Biosciences Inc Vacunas frente al virus del herpes simple de tipo 2: composiciones y métodos para provocar una respuesta inmunitaria
KR101008582B1 (ko) * 2010-09-20 2011-01-17 (주)칠칠공사 달비계용 2중 안전 샤클조립체
CA2856697A1 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
JP6199878B2 (ja) * 2011-11-23 2017-09-20 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法
AU2014203873A1 (en) 2013-01-07 2015-07-30 Biomedical Research Models, Inc. Therapeutic vaccines for treating herpes simplex virus type 2 infections
AU2015225499B2 (en) 2014-03-03 2020-05-14 Albert Einstein College Of Medicine, Inc. Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
CN104721839A (zh) * 2015-03-17 2015-06-24 浙江省医学科学院 一种预防单纯疱疹病毒ii型的疫苗
CN104830781A (zh) * 2015-05-05 2015-08-12 杨光华 基于hsv-2抗原的dc细胞、靶向性免疫细胞群及其制备方法和用途
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物
WO2019044925A1 (ja) * 2017-08-30 2019-03-07 Ｋｍバイオロジクス株式会社 改変型ＨＳＶ ｇＤタンパク質及びこれを含むワクチン

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488936B1 (en) * 1998-02-12 2002-12-03 Wyeth Immunogenic composition of interleukin-12 (IL-12), alum, herpes simplex viral (HSV) antigen, and method thereof

Also Published As

Publication number Publication date
WO2001044477A1 (en) 2001-06-21
AU2065101A (en) 2001-06-25
CN1222619C (zh) 2005-10-12
KR100773390B1 (ko) 2007-11-09
EP1238086B1 (en) 2006-03-08
EP1238086A1 (en) 2002-09-11
MXPA02005867A (es) 2002-10-23
JP2003517042A (ja) 2003-05-20
CA2406678A1 (en) 2001-06-21
DE60026588T2 (de) 2007-01-18
PT1238086E (pt) 2006-07-31
ATE319833T1 (de) 2006-03-15
AU783730B2 (en) 2005-12-01
CY1105604T1 (el) 2010-07-28
KR20020073348A (ko) 2002-09-23
ES2258987T3 (es) 2006-09-16
BR0016419A (pt) 2002-08-20
IL149810A0 (en) 2002-11-10
DE60026588D1 (de) 2006-05-04
CN1434864A (zh) 2003-08-06

Similar Documents

Publication Publication Date Title
CY1105604T1 (el) Μεθοδος ενισχυσης ανοσων απαντησεων στο εμβολιο κατα του ιου του απλου ερπητα
DK0587780T3 (da) Smitstof, som forårsager Mystery Swine Disease, vaccinepræparater og diagnostiske sæt
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
DK0851927T3 (da) Forbindelser til immunterapi og diagnosticering af tuberkulose
CA2660355A1 (en) Polynucleotide vaccine formulation against pathologies of the horse
FI953608A (fi) Rokoteyhdisteet ja menetelmä immuunireaktion aikaansaamiseksi limakalvossa järjestelmällisellä rokottamisella
BRPI0408779A (pt) uso de composições, composição imunogênica e kit
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
DE60125797D1 (de) Impfstoffzusammesetzung
WO1998053075A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
BR0014138A (pt) Uso de um vetor adenoviral deficiente em replicação, e, métodos para reforçar, e para induzir resposta imune de célula cd8+ t a um antìgeno em um indivìduo
WO2002024739A3 (en) Spas-1 cancer antigen
DK0806966T3 (da) Katoniske copolymerer af vinylamin og vinylalkohol til administration af oligonukleotider
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
WO1996018646A3 (en) Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
BR0115646A (pt) Composição, dispositivo de liberação de partìculas, uso de uma composição, e, método para intensificar uma resposta imune contra um antìgeno de interesse em um paciente
AU8467201A (en) Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
ATE310750T1 (de) Verotoxin b untereinheit zur immunisierunug
WO1999053960A3 (en) Enhancing immune responses to genetic immunization by using a chemokine
BR0013574A (pt) Antìgeno vacina de moraxella
DE69937258D1 (de) Genetische impstoffe mit adjuvans
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
BR0213554A (pt) Timosina para aumento da imunização genética